|

Furmonertinib 320mg qod po Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Guangzhou University of Traditional Chinese Medicine1

Indications

  • Furmonertinib1
  • EGFR Activating Mutation1
  • NSCLC (Advanced Non-small Cell Lung Cancer)1
  • Lung Cancer1
  • Leptomeningeal Metastasis1

Other1 trial

Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.